Ординатура / Офтальмология / Английские материалы / Handbook of Pediatric Retinal Disease_Wright, Spiegel, Thompson_2006

40.Cibis G, Fitzgerald K. Abnormal electroretinogram associated with developmental brain anomalies. Trans Am Ophthalmol Soc 1995;93: 147–158; discussion 158–161.

41.Cicedyian A, Jacobsen S. Negative electroretinograms in retinitis pigmentosa. Investiag Ophthalmol Vis Sci 1993;34:3253–3263.

42.Cohen S, Brown F, Martyn L, et al. Ocular histopathologic and biochemical studies of the cerebrohepatorenal syndrome (Zellweger’s syndrome) and its relationship to neonatal adrenoleucodystrophy. Am J Ophthalmol 1983;96:488–501.

43.Creel D, Bendel C, Wiesner G, et al. Abnormalities of the central visual pathways in Prader-Willi syndrome associated with hypopigmentation. N Engl J Med 1986;314(25):1606–1609.

44.Creel D, Spekreijse H, Reits D. Evoked potentials in albinos: efficacy of pattern stimulation in detecting misrouted optic fibres. Electroencephalogr Clin Neurophysiol 1981;52:595–603.

45.Crews S, Thompson C, Harding G. The ERG and VEP in patients with severe eye injury. Doc Ophthalmol 1978;15:203–209.

46.Dekaban A. Hereditary syndrome of congenital blindness (Leber), polycystic kidneys and maldevelopment of the brain. Am J Ophthalmol 1969;689:1029–1036.

47.Dell’Osso L. Seesaw nystagmus in dogs and humans: an international, across discipline, serendipitous collaboration. Neurology 1996;47:1372–1374.

48.De Vries Khoe L, Spekreijse H. Maturation of luminance and pattern EPs in man. Doc Ophthalmol 1982;31:461–475.

49.Dorfman L, Nikoskelianen E, Rosenthal A, et al. Visual evoked potentials in Leber’s optic neuropathy. Ann Neurol 1977;1:565–568.

50.Drasdo N, Edwards L, Thompson D. Models of the visual cortex based on visual evoked potentials. In: Gulyas B, Ottoson D, Roland P (eds) Functional organization of the human visual cortex. Wenner Gren international series, vol 61. Oxford: Pergamon Press, 1993: 255–270.

51.Drasdo N, Thompson D, Arden G. A comparison of pattern ERG amplitudes and nuclear layer thickness in different zones of the retina. Clin Vis Sci 1990;5:415–420.

52.Eke T, Talbot J, Lawden M. Severe persistent visual field constriction associated with vigabatrin [see comments]. Br Med J 1997; 314(7075):180–181.

53.Esakowitz L, Kriss A, Shawkat F. A comparison of flash electroretinograms recorded from Burian Allen, JET, C-Glide, gold foil, DTL, and skin electrodes. Eye 1993;7:169–171.

54.Fagan E, Taylor M. Longitudinal multimodal evoked potential studies in abetalipoproteinaemia. Can J Neurol Sci 1987;14:617–621.

55.Farley M, Heckenlively J. Blue cone monochromatism. In: Heckenlively J, Arden G (eds) Principles and practice of clinical electrophysiology of vision. St. Loius: Mosby, 1991:753–755.

56.Fellman D, Van Essen D. Distributed hierarchical processing in the primate visual cortex. Cereb Cortex 1991;1:1–47.

57.Fitzgerald K, Hashimoto T, Hug T, et al. Autosomal dominant inheritance of a negative electroretinogram in three generations. Am J Ophthalmol 2001;131(4):495–502.

58.Fitzgerald K, Cibis G, Giambrone S, et al. Retinal signal transmission in Duchenne muscular dystrophy: evidence for dysfunction in the photoreceptor depolarising bipolar cell pathway. J Clin Investig 1994;93:2425–2430.

59.Flanagan J, Harding G. Multichannel visual evoked potentials in early compressive lesions of the optic chiasm. Doc Ophthalmol 1987;69:271–282.

60.Flaxel C, Jay M, Thiselton D, et al. Difference between RP2 and RP3 phenotypes in X linked retinitis pigmentosa. Br J Ophthalmol 1999;83(10):1144–1148.

61.Fulton A, Hansen R, Glynn R. Natural course of visual functions in the Bardet-Biedl syndrome. Arch Ophthalmol 1993;111(11):1500– 1506.

62.Fulton A, Hansen R. Electroretinography: application to clinical studies of infants. J Pediatr Ophthalmol Strabismus 1985;22(6): 251–255.

63.Fulton A, Hartmann E, Hansen R. Electrophysiological testing techniques for children. Doc Ophthalmol 1989;71:341–354.

64.Galloway N. Electrophysiological testing of eyes with opaque media. Eye 1988;2:615–624.

65.Garbern J, Cambi F, Shy M, et al. The molecular pathogenesis of Pelizaeus-Merzbacher disease. Arch Neurol 1999;56(10):1210– 1214.

66.Garner A, Fielder A, Primavesi R, et al. Tapetoretinal degeneration in the cerebro-hepato-renal (Zellweger) syndrome. Br J Ophthalmol 1982;66:422–431.

67.Gerritsen E, Vossen J, van Loo, et al. Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics 1994;93:247–253.

68.Givre S, Schroeder C, Arezzo J. Contribution of extra striate area V4 to the surface recorded flash VEP in the awake macaque. Vision Res 1994;34:415–428.

69.Gottlob I, Fendick M, Guo S, et al. Visual acuity measurements by swept spatial frequency visual-evoked-cortical potentials (VECPs): clinical application in children with various visual disorders. J Pediatr Ophthalmol Strabismus 1990;27(1):40–47.

70.Granit R. Sensory mechanisms of the retina. London: Oxford University Press, 1947.

71.Grant C, Berson E. Treatable forms of retinitis pigmentosa associated with systemic neurological disorders. Int Ophthalmol Clin 2001;41(1):103–110.

72.Grieshaber M, Boltshauser E, Niemeyer G. Leber’s congenital amaurosis. Clinical heterogeneity and electroretinography in 27 patients. In: Hollyfield X, et al. (eds) Retinal degenerative diseases and experimental therapy. New York: Kluwer, 1999:95–104.

73.Groswasser Z, Kriss A, Halliday AM, et al. Pattern and flash evoked potentials in the assessment and management of optic nerve gliomas. J Neurol Neurosurg Psychiatry 1985;48:1125–1134.

74.Grover S, Fishman G, Anderson R, et al. A longitudinal study of visual function in carriers of X-linked recessive retinitis pigmentosa. Ophthalmology 2000;107(2):386–396.

75.Haegerstrom-Portnoy G, Schneck M, Verdon W, et al. Clinical vision characteristics of the congenital achromatopsias. II. Color vision. Optom Vis Sci 1996;73(7):457–465.

76.Haegerstrom-Portnoy G, Schneck M, Verdon W, et al. Clinical vision characteristics of the congenital achromatopsias. I. Visual acuity, refractive error, and binocular status. Optom Vis Sci 1996;73(7):446– 456.

77.Haider N, Jacobsen S, Cideciyan A, et al. Mutation of a nuclear receptor gene, NR2E3, causes enhanced cone syndrome, a disorder of retinal cell fate. Nat Genet 2000;24:127–131.

78.Halliday A. Evoked potentials in clinical testing, 2nd edn. Edinburgh: Churchill Livingstone, 1993.

79.Halliday A, Barrett G, Blumhardt L, et al. The macular and paramacular components of the pattern evoked response. In: Lehmann D, Calloway E (eds) Human evoked potentials: applications and problems. New York: Plenum Press, 1979:135–151.

80.Halliday A, McDonald W, Mushin J. Delayed pattern evoked responses in optic neuritis in relation to visual acuity. Trans Ophthalmol Soc UK 1973;93:315–324.

81.Halliday A, Kriss A, Cuendent F, et al. Childhood optic neuritis: a study of flash and pattern evoked potentials. In: Gallai V (ed) Maturation of the CNS and evoked potentials. Amsterdam: Elsevier, 1986:41–50.

82.Hamer R, Norcia A, Tyler C, et al. The development of monocular and binocular VEP acuity. Vision Res 1989;29(4):397–408.

83.Harden A, Pampiglione G. Neurophysiological studies (EEG/ ERG/VEP/SEP) in 88 children with so-called neuronal ceroid lipofuscinosis. In: Armstrong D, Koppang N, Rider JA (eds) Ceroid lipofuscinosis (Batten’s disease). Amsterdam: Elsevier, 1982:61–70.

84.Harding G, Wild J, Robertson K, et al. Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss [see comments]. Neurology 2000;55(3):347–352.

85.Harding G, Wild J, Robertson K, et al. Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction. Epilepsia 2000;41(11):1420–1431.

86.Harding G, Crews S. The VER in hereditary optic atrophy of the dominant type. In: Mauguiere F, Courjon F (eds) The clinical applications of evoked potentials in neurology. New York: Raven Press, 1982:21–30.

87.Harding G, Williams D, Innes J. The visual evoked potentials and psychophysics during ethambutol therapy. In: Nodar RH, Barber

C (eds) Evoked potentials, vol ll. Boston: Butterworth, 1984:339– 344.

88.Harris C. Nystagmus and eye movement disorders. In: Taylor D (ed) Pediatric ophthalmology. Oxford: Blackwell, 1997:869–896.

89.Hawksworth N, Headland S, Good P, et al. Aland Island eye disease: clinical and electrophysiological studies of a Welsh family. Br J Ophthalmol 1995;79(5):424–430.

90.Holder G. Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. In: Fishman GA, Birch D, Holder GE, Brigell M (eds) Electrophysiological testing in disorders of retinal optic nerve, and visual pathway. 2001.

91.Hood D, Birch D. Abnormalities of the retinal cone system in retinitis pigmentosa. Vision Res 1996;36(11):1699–1709.

92.Hood D, Birch D. Assessing abnormal rod photoreceptor activity with the a-wave of the electroretinogram: applications and methods. Doc Ophthalmol 1996–97;92(4):253–267.

93.Hoyt C, Billson F. Visual loss in osteopetrosis. Am J Dis Child 1979;133:955–958.

94.Hutton W, Fuller D. Factors influencing final visual results in severely injured eyes. Am J Ophthalmol 1984;97:715–722.

95.Iannoccone A, De-Propris G, Roncati S, et al. The ocular phenotype of the Bardet-Biedl syndrome. Comparison to non-syndromic retinitis pigmentosa. Ophthalmic Genet 1997;18:13–26.

96.Jabbari B, Maitland C, Morris L, et al. The value of visual evoked potential as a screening test in neurofibromatosis. Arch Neurol 1985; 42:1072–1074.

97.Jacobs M, Shawkat F, Harris C, et al. Eye movement and electrophysiological findings in an infant with hemispheric pathology. Dev Med Child Neurol 1993;35(5):431–435.

98.Jeffreys D, Axford J. Source localisations of pattern-specific components of human visual evoked potentials l. Component of striate cortical origin. Exp Brain Res 1972;6:1–21.

99.Jeffreys D, Axford J. Source localisations of pattern-specific components of human visual evoked potentials. ll. Component of extrastriate cortical origin. Exp Brain Res 1972;6:22–40.

100.Jensen H, Warburg M, Sjo O, et al. Duchenne muscular dystrophy: negative electroretinograms and normal dark adaptation. Reappraisal of assignment of X-linked incomplete congenital stationary night blindness. J Med Genet 1995;32(5):348–351.

101.Jiang C, Hansen R, Gee B, et al. Rod and rod mediated function in patients with beta-thalassemia major. Doc Ophthamol 1998–99; 96(4):333–345.

102.Joubert M, Eisenring J, Robb J, et al. Familial agenesis of the cerebellar vermis: a syndrome of episodic hyperapnea, abnormal eye movements, ataxia, and retardation. 1969 [classical article]. J Child Neurol 1999;14(9):554–564.

103.Keith C. Retinal atrophy in osteopetrosis. Arch Ophthalmol 1968;79: 234–241.

104.Kellner U, Weleber R, Kennaway N, et al. Gyrate atrophy-like phenotype with normal plasma ornithine. Retina 1997;17(5):403– 413.

105.Kellner U, Foerster M. Cone dystrophies with negative photopic electroretinogram. Br J Ophthalmol 1993;77(7):404–409.

106.Klevering B, van-Driel M, van de Pol D, et al. Phenotypic variations in a family with retinal dystrophy as result of different mutations in the ABCR gene. Br J Ophthalmol 1999;83(8):914–918.

107.Kondo M, Sieving P. Primate photopic sine-wave flicker ERG: vector modeling and component origins using glutamate analogs. Investig Ophthalmol Vis Sci 2001;42(1):305–312.

108.Kraemer M, Abrahamsson M, Sjostrum A. The neonatal development of the light flash visual evoked potential. Doc Ophthalmol 1999;99:21–39.

109.Krauss G, Johnson M, Miller N. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings [see comments]. Neurology 1998;51(6):1778–1779; discussion 1779– 1781.

110.Kretschmann U, Seeliger M, Ruether K, et al. Multifocal electroretinography in patients with Stargardt’s macular dystrophy. Br J Ophthalmol 1998;82(3):267–275.

111.Kriss A, Thompson D, Lavy T, et al. Pattern VEPs and craniopharyngiomas in children. Investig Ophthalmol Vis Sci 1996;37: 1075.

112.Kriss A, Russell-Eggitt I, Harris C, et al. Aspects of albinism. Ophthalmol Paediatr Genet 1992;13:89–100.

113.Kriss A, Thompson D, Lloyd I, et al. Pattern VEP findings in young children treated for unilateral congenital cataract. In: Cottlier E (ed) Congenital cataracts. Austin: Landes, 1994:79–88.

114.Kriss A, Carroll W, Blumhardt L, et al. Pattern and flash evoked potential changes in toxic (nutritional) optic neuropathy. In: Courjon J, Maugiere F, Revol M (eds) Clinical applications of evoked potentials in neurology. Advances in neurology, vol 32. New York: Raven Press, 1982:11–19.

115.Kriss A, Francis D, Cluendet F, et al. Recovery from optic neuritis in childhood. J Neurol Neurosurg Psychiatry 1988;51:1253–1258.

116.Kriss A, Thompson D. Visual electrophysiology. In: Taylor D (ed) Pediatric ophthalmology. Oxford: Blackwell, 1997:93–121.

117.Kriss A, Russell-Eggitt I. Electrophysiological assessment of visual pathway function in infants. Eye 1992;6:145–153.

118.Kriss A, Russell-Eggitt I, Harris C, et al. Aspects of albinism. Ophthalmol Paediatr Genet 1992;13:89–100.

119.Kubova Z, Kuba M. Clinical application of motion onset potentials. Doc Ophthalmol 1992;81:209–218.

120.Kupersmith M, Siegel I, Carr R, et al. Visual evoked potentials in chiasmal gliomas in four adults. Arch Neurol 1981;38:362–366.

121.Lachapelle P, Rousseau S, McKerral M, et al. Evidence supportive of a functional discrimination between photopic oscillatory potentials

as revealed with cone and rod mediated retinopathies. Doc Ophthalmol 1998;95(1):35–54.

122.Lachapelle P, Little J, Polomeno R. The photopic electroretinogram in congenital stationary night blindness with myopia. Investig Ophthalmol Vis Sci 1983;24:442–450.

123.Lambert R, Kriss A, Taylor D. Delayed visual maturation; a longitudinal clinical and electrophysiological assessment. Ophthalmology 1989;96:534–529.

124.Lambert S, Taylor D, Kriss A. The infant with nystagmus, normal appearing fundi but an abnormal ERG. Surv Ophthalmol 1989;34: 176–186.

125.Lambert S, Kriss A, Taylor D. Detection of isolated occipital lobe anomalies during early childhood. Dev Med Child Neurol 1990; 32(5):451–455.

126.Lambert S, Kriss A, Taylor D. Joubert syndrome. Arch Ophthalmol 1989;107:709–713.

127.Lambert S, Taylor D, Kriss A, et al. Follow-up and diagnostic reappraisal of 75 patients with Leber’s congenital amaurosis. Am J Ophthalmol 1989;107:624–631.

128.Lang G, Maumenee I. Retinal dystrophies associated with storage diseases. In: Newsome DA (ed) Retinal dystrophies and degenerations. New York: Raven Press, 1988:319–340.

129.Lavy T, Harris C, Shawkat F, et al. Electrophysiological and eye movement abnormalities in children with the Bardet-Biedl syndrome. J Pediatr Ophthalmol Strabismus 1995;32(6):364–367.

130.Lei B, Bush R, Milam A, et al. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Investig Ophthalmol Vis Sci 2000;41(1): 262–266.

131.Lennerstrand G. Delayed visual evoked cortical potentials in retinal disease. Acta Ophthalmol (Copenh) 1982;60:497–504.

132.Livingstone M, Hubel D. Segregation of form, colour, movement and depth: anatomy, physiology and perception. Science 1988;240:740– 750.

133.Lois N, Holder G, Bunce C, et al. Phenotypic subtypes of Stargardt’s macular dystrophy-fundus flavimaculatus. Arch Ophthalmol 2001;119(3):359–369.

134.Lorenz B, Gampe E. Analyse von 180 Patienten mit sensorischem Defektnystagmus (SDN) und kongenitalem idiopathischen Nystagmus (CIN). [Analysis of 180 patients with sensory defect nystagmus (SDN) and congenital idiopathic nystagmus (CIN).] Klin Monatsbl Augenheilkd 2001;218(1):3–12.

135.Mandelbaum S, Cleary P, Ruan S, et al. Bright flash electroretinography and vitreous haemorrhage. Arch Ophthalmol 1980;98:1823– 1828.

136.Marg E, Freeman D, Peltzman P, et al. Visual acuity development in human infants: evoked potential measurements. Investig Ophthalmol Vis Sci 1976;15:150–153.

137.Markwardt F, Gopfert E, Muller R. Influence of velocity, temporal frequency and initial phase position of gratings on the motion VEP. Biomed Biochim Acta 1988;47:753–760.

138.Marmor M, Jacobsen S, Foerster M, et al. Diagnostic findings of a new syndrome with night blindness, maculopathy, and enhanced s cone sensitivity. Am J Ophthalmol 1990;110:124–134.

139.Maugeri A, Klevering B, Rohrschneider K, et al. Mutations in the ABCA4 (ABCR) gene are the major cause of autosomal recessive cone-rod dystrophy. Am J Hum Genet 2000;67(4):960–966.

140.McCulloch D, Skarf B. Pattern reversal visual evoked potentials following early treatment of unilateral, congenital cataract [see comments]. Arch Ophthalmol 1994;112(4):510–518.

141.McCulloch D, Orbach H, Skarf B. Maturation of the pattern reversal VEP in human infants: a theoretical framework. Vision Res 1999;39:3673–3680.

142.Merigan W. P and M pathway specialisation in the macaque. In: Valberg A, Lee B (eds) From pigments to perception: advances in understanding visual processes. NATO ASI series no. 203. New York: Plenum Press, 1991;117–125.

143.Miyake Y, Horiguchi M, Suzuki S, et al. Electrophysiological findings in patients with Oguchi’s disease. Jpn J Ophthalmol 1996;40(4): 511–519.

144.Miyake Y, Horiguchi M, Terasaki H, et al. Scotopic threshold response in complete and incomplete types of congenital stationary night blindness. Investig Ophthalmol Vis Sci 1994;35:3770–3775.

145.Miyake Y, Yagasaki K, Horiguchi M, et al. Congenital stationary night blindness with a negative electroretinogram: a new classification. Arch Ophthalmol 1986;104:1013–1020.

146.Miyake Y, Shiroyama N, Horiguchi M, et al. Bull’s eye maculopathy and negative electroretinograms. Retina 1989;9:210–215.

147.Mohri I, Taniike M, Fujimura H, et al. A case of Kearns-Sayre syndrome showing a constant proportion of deleted mitochondrial DNA in blood cells during 6 years of follow-up. J Neurol Sci 1998;158(1): 106–109.

148.Moskowitz A, Sokol S. Spatial and temporal interaction of patternevoked cortical potentials in human infants. Vision Res 1980;20(8): 699–707.

149.Mullie M, Harding A, Petty R, et al. The retinal manifestations of mitochondrial myopathy: a study of 22 cases. Arch Ophthalmol 1985;103:1825–1830.

150.Multifocal electroretinography: special issue. The multifocal technique: topographic ERG and VEP responses. Doc Ophthalmol 2001; 100:49–251.

151.Nakamura M, Ito S, Terasaki H, et al. Novel CACNA1F mutations in Japanese patients with incomplete congenital stationary night blindness. Investig Ophthalmol Vis Sci 2001;42(7):1610–1616.

152.Niemeyer G. Pharmacological effects in retinal electrophysiology. In: Heckenlively JR, Arden GB (eds) Principles and practice of

clinical electrophysiology of vision. St. Louis: Mosby, 1991:151– 162.

153.Norcia A, Tyler C, Hamer R, et al. Measurement of spatial contrast sensitivity with the swept contrast VEP. Vision Res 1989;29(5): 627–637.

154.Norcia A, Tyler C. Infant VEP acuity measurements: analysis of individual differences and measurement error. Electroencephalogr Clin Neurophysiol 1985;61(5):359–369.

155.Norcia A, Tyler C. Spatial frequency sweep VEP: visual acuity during the first year of life. Vision Res 1985;25(10):1399–1408.

156.Norcia A, Garcia H, Humphrey R, et al. Anomalous motion VEPs in infants and infantile esotropia. Investig Ophthalmol Vis Sci 1991; 32:436–439.

157.Novack G. Ocular toxicology. Curr Opin Ophthalmol 1997;8(6):88– 92.

158.Nusinowitz S, Birch D, Birch E. Rod photoresponses in 6-week and 4-month-old human infants. Vision Res 1998;38(5):627–635.

159.Nuwer M, Perlman S, Packwood J, et al. Evoked potential abnormalities in the various inherited ataxia. Ann Neurol 1983;13:20–27.

160.Orel-Bixler D, Norcia A. Differential growth for steady state pattern reversal and transient onset offset VEPs. Clin Vis Sci 1987;2:1–10.

161.Orel-Bixler D, Haegerstrom-Portnoy G, Hall A. Visual assessment of the multiply handicapped patient. Optom Vis Sci 1989;66(8): 530–536.

162.Ossenblock P, Spekreijse H. The extra-striate generators of the EP to checkerboard onset. A source localisation approach. Electroencephalogr Clin Neurophysiol 1991;80:181–193.

163.Palczewski K. Is vertebrate phototransduction solved? New insights into the molecular mechanism of phototransduction. Investig Ophthalmol Vis Sci 1994;35(10):3577–3581.

164.Papaioannou M, Ocaka L, Bessant D, et al. An analysis of ABCR mutations in British patients with recessive retinal dystrophies. Investig Ophthalmol Vis Sci 2000;41(1):16–19.

165.Papakostopoulos D, Hart C, Cooper R, et al. Combined electrophysiological assessment of the visual system in central serous retinopathy. Electroencephalogr Clin Neurophysiol 1984;59(1):77– 80.

166.Patel C, Taylor D, Russell-Eggitt I, et al. Congenital third nerve palsy associated with mid-trimester amniocentesis. Br J Ophthalmol 1993;77:530–533.

167.Pepperberg D, Birch D, Hood D. Photoresponses of human rods derived from paired flash ERGs. Vis Neurosci 1997;14:73–82.

168.Poggi-Travert F, Fournier B, Poll B, et al. Clinical approach to inherited peroxisomal disorders. J Inherit Metab Dis 1995;18(suppl 1): 1–18.

169.Porteous W, James A, Sheard P, et al. Bioenergetic consequences of accumulating the common 4977-bp mitochondrial DNA deletion. Eur J Biochem 1998;257(1):192–201.

170.Pryds O, Greisen G. Preservation of single flash visual evoked potentials at very low cerebral oxygen delivery in preterm infants. Pediatr Neurol 1990;6:151–158.

171.Pugh E, Lamb T. Phototransduction in vertebrate rods and cones: molecular mechanisms of amplification, recovery and light adaptation. In: Stavenga DG, de Grip WJ, Pugh EN Jr (eds) Handbook of biological physics, vol 3. Amsterdam: Elsevier, 2000:183–254.

172.Purvin V, Kawasaki A, Yee R. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol 2000;118:1626–1630.

173.Reardon W, Winter R. The molecular pathology of syndromic craniosynostosis. Mol Med Today 1995:432–437.

174.Regan D. Human brain electrophysiology. Amsterdam: Elsevier, 1989.

175.Regan D, Spekreijse H. Evoked potential indicators of colour blindness. Vision Res 1974;14:89–95.

176.Regan D, Regal D, Tibbles J. Evoked potentials during recovery from blindness recorded serially from an infant and his normally sighted twin. Electroencephalogr Clin Neurophysiol 1982;54:465–468.

177.Ripps H, Mahaffy L, Siegel I, et al. Vincristine-induced changes in the retina of isolated arterially perfused cat eye. Exp Eye Res 1989;48:771–790.

178.Robson J, Frishman L. Dissecting the dark-adapted electroretinogram. Doc Ophthalmol 1998–99;95(3–4):187–215.

179.Rozet J, Gerber S, Ghazi I, et al. Mutations of the retinal specific ATP binding transporter gene (ABCR) in a single family segregating both autosomal recessive retinitis pigmentosa RP19 and Stargardt’s disease: evidence of clinical heterogeneity at this locus. J Med Genet 1999;36(6):447–451.

180.Runge P, Muler D, McAllister J, et al. Oral vitamin E can prevent the retinopathy of abetalipoproteinaemia. Br J Ophthalmol 1986;70: 166–173.

181.Russell-Eggitt I, Harris M, Kriss A. Delayed visual maturation: an update. Dev Med Child Neurol 1998;40:130–136.

182.Sandberg M, Wiegel-DiFranco C, Drya T, et al. Clinical expression correlates with location of rhodopsin mutation in dominant retinitis pigmentosa. Investig Ophthalmol Vision Sci 1995;36:1934–1942.

183.Schaumberg D, Moyes A, Gomes J, et al. Corneal transplantation in young children with congenital hereditary endothelial dystrophy. Multicenter Pediatric Keratoplasty Study. Am J Ophthalmol 1999; 127(4):373–378.

184.Schroeder C, Tenke C, Givre S, et al. Striate cortical contribution to the surface recorded pattern reversal VEP in the alert monkey. Vision Res 1991;3197(80):1143–1157 [also published erratum Vision Res 191;31(11):1].

185.Seiple W, Holopigian K. An examination of VEP response phase. Electroencephalogr Clin Neurophysiol 1989;73(6):520–531.

186.Sharon D, Bruns G, Mcgee T, et al. X-linked retinitis pigmentosa: mutation spectrum of the RPGR and RP2 genes and correlation with visual function. Investig Ophthalmol Vis Sci 2000;41:2712–2721.

187.Sharpe L, Stockman A. Rod pathways: the importance of seeing nothing. Trends Neurosci 1999;22:497–504.

188.Shawkat F, Kriss A. A study of the effects of contrast change on pattern VEPs, and the transition between onset, reversal and offset modes of stimulation. Doc Ophthalmol 2000;101(1):73– 89.

189.Shepherd A, Saunders K, McCulloch D, et al. Prognostic value of flash visual evoked potentials in preterm infants. Dev Med Child Neurol 1999;41:9–155.

190.Sieving P. Photopic ONand OFF-pathway abnormalities in retinal dystrophies. AOS thesis. Trans Am Ophthalmol Soc 1993;LXXXXl: 701–773.

191.Sieving P, Murayama K, Naarendorp F. Push-pull model of the primate photopic electroretinogram: a role for hyperpolarizing neurons in shaping the b-wave. Vis Neurosci 1994;11:519–532.

192.Sieving P, Bingham E, Kemp J, et al. Juvenile X-linked retinoschisis from XLRS1 Arg213Trp mutation with preservation of the electroretinogram scotopic b-wave. Am J Ophthalmol 1999;128(2): 179–184.

193.Sieving P, Frishman L, Steinberg R. Scotopic threshold response of proximal retina in cat. J Neurophysiol 1986;5694:1049–1061.

194.Sigesmund D, Weleber R, Pillers D, et al. Characterization of the ocular phenotype of Duchenne and Becker muscular dystrophy. Ophthalmology 1994;101(5):856–865.

195.Skoczenski A, Norcia A. Development of VEP vernier acuity and grating acuity in human infants. Investig Ophthalmol Vis Sci 1999;40:2411–2417.

196.Smith L, Kriss A, Gregson R, et al. Gaze evoked amaurosis in neurofibromatosis type ll. Br J Ophthalmol 1998;82:584–585.

197.Smith N, Lamb T. The a-wave of the human electroretinogram recorded with a minimally invasive technique. Vision Res 1997; 37(21):2943–2952.

198.Smith R, Berlin C, Hejtmancik J, et al. Clinical diagnosis of the Usher syndromes. Am J Med Genet 1994;50:32–38.

199.Snead M, Payne S, Barton D, et al. Stickler syndrome: correlation between vitreoretinal phenotypes and linkage to COL 2A1. Eye 1994;8:609–614.

200.Sokol S. Measurements of infant visual acuity from pattern-reversal evoked potentials. Vision Res 1978;18(1):33–39.

201.Sokol S, Moskowitz A. Comparison of pattern VEPs and preferentiallooking behavior in 3-month-old infants. Investig Ophthalmol Vis Sci 1985;26(3):359–365.

202.Soong F, Levin A, Westall C. Comparison of techniques for detecting visually evoked potential asymmetry in albinism. J Am Assoc Pediatr Ophthalmol Sci 2000;4:302–310.

203.Spileers W, Maes H, Van Hulle M, et al. Contrast modulated steady state evoked potentials (CMSS VEPS) measuring static and dynamic contrast sensitivity. Clin Vis Res 1992;7:93–106.